Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smarter prostate screening: a new risk score aims to cut unnecessary biopsies

NCT ID NCT06678828

ENROLLING_BY_INVITATION Diagnosis Sponsor: Nanostics Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial is testing whether a blood-based risk score called ClarityDX Prostate can help doctors decide which men truly need an MRI or biopsy when checking for prostate cancer. The test combines standard PSA levels with age and other factors to give a personalized risk estimate. Researchers will compare men whose doctors see the test result against those who receive usual care, to see if the test reduces unnecessary procedures without missing dangerous cancers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ClarityDX Prostate, a blood-based risk score combining PSA levels, age, and prior biopsy history to predict clinically significant prostate cancer
What this could lead to
If successful, this test could help many men avoid unnecessary biopsies and MRIs while still catching dangerous prostate cancers early.
What could go wrong
The test is still being validated in a large trial; it may not reduce procedures as hoped or could miss some cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATE CANCER SCREENING PROSTATE CANCER SCREENING DECISION

Contacts and locations

Locations

  • Kipnes Urology Centre

    Edmonton, Alberta, T6G 1Z1, Canada

  • Men's Health Clinic, Manitoba

    Winnipeg, Manitoba, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, Canada

  • Prostate Cancer Centre

    Calgary, Alberta, Canada

  • Vancouver Prostate Center

    Vancouver, British Columbia, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.